219
Participants
Start Date
February 28, 2007
Primary Completion Date
September 30, 2012
Study Completion Date
June 30, 2014
CP-751,871
CP-751,871 given at 20 mg/kg IV on day 1 of each 21 day cycle.
exemestane
Exemestane given at 25 mg orally once a day.
exemestane
Exemestane given at 25 mg orally once a day. Treatment until progression or toxicity
Fulvestrant
Used for salvage therapy and administered according to the local label and standard clinical practice.
Dana-Farber Cancer Institute, Boston
Oncologisch Centrum GZA, Wilrijk
UZ Gasthuisberg, Medische Oncologie, Leuven
UZ Gasthuisberg, Leuven
Fletcher Allan Health Care, Burlington
Dipartimento di Medicina, Divisione di Oncologia Medica, Istituto Europeo di Oncologia, Milan
Duke University Medical Center - Morris Cancer Center Clinics, Durham
Duke University Medical Center- Department of Medicine Oncology, Durham
Duke University Medical Center-Duke Cancer Center, Durham
Duke University Medical Center, Durham
Duke University School Of Medicine, Durham
Florida Cancer Research Institute, Plantation
Florida Cancer Research Institute, Davie
Uo Oncologia Medica 2 Regione Del Veneto Istituto Oncologico Veneto IRCCS Ospedale Busonera, Padua
Central Baptist Hospital, Lexington
Lexington Oncology Associates, Lexington
Bluegrass Hematology/Oncology, PSC, Lexington
University of Minnesota Medical Center-Fairview, Riverside Campus, Minneapolis
University of Minnesota Cancer Center, Minneapolis
University Of Minnesota Medical Center, Minneapolis
Baylor College Of Medicine (Bcm), Houston
Baylor College of Medicine Breast Center, Houston
Divisione di Oncologia, Napoli
UCSD Medical Center - La Jolla, La Jolla
UCSD Moores Cancer Center, La Jolla
UCSD Medical Center - Hillcrest, San Diego
Washington Cancer Institute (WCI) at Washington Hospital Center (WHC), Washington D.C.
Massachusetts General Hospital, Boston
Bringham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute (DFCI), Boston
Alamance Regional Medical Center - Cancer Center, Burlington
Texas Oncology - PA Collins Building 5th Floor, Dallas
Fletcher Allen Healthcare, Burlington
Fletcher Allen Health Care, Burlington
Fletcher Allen Hospital MCHV Campus, Burlington
Pharmacist, Investigational Drug Service, Burlington
Fletcher Allen Healthcare, Burlington
Policlinica Privada Site La Plata S.A., La Plata
Breast Clinica de la Mama, La Plata
Policlinica Privada Site, La Plata
Policlinica Privada Site La Plata S. A., La Plata
Hospital Italiano Cordoba, Córdoba
Instituto de Investigaciones Clinicas, Rosario
Centro Oncologico Rosario, Rosario
Centro Oncologico De Rosario, Rosario
Centro Oncologico, Rosario
Jewish General Hospital, Montreal
Sir Mortimer B. Davis - Jewish General Hospital, Montreal
Instituto Nacional DO Cancer - INCA, Rio de Janeiro
Instituto Nacional de Cancer - HCII, Santo Cristo
Clínica de Oncologia de porto Alegre Sociedade Simples ltda., Porto Alegre
Hospital Sao Lucas da PUCRS, Porto Alegre
Centro de Pesquisa em Oncologia - CPO, Porto Alegre
Hospital Das Clinicas Da Faculdade De Medicina Da Universidade De Sao Paulo Instituto Central, São Paulo
Instituto Nacional do Cancer, Rio de Janeiro
Cross Cancer Institute, Edmonton
VU University Medical Center, Amsterdam
Malmö University Hospital, Malmo
St Mary's Hospital NHS Trust, London
Imperial College Healthcare NHS Trust - Charing Cross Hospital, London
Lead Sponsor
Pfizer
INDUSTRY